v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ 10,659 $ (7,115)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 17,062 26,304
Amortization of deferred financing costs 484 485
Credit loss expense 24  
Deferred income tax benefit (11) (3,692)
Equity-based employee and director compensation expense 201 813
Gain on dispositions and lease terminations, net (6,116) (5,037)
Changes in operating assets and liabilities, net of acquisitions 5,574 3,289
Net cash provided by operating activities 27,877 15,047
Cash flows from investing activities:    
Principal payments received on notes receivable 23 34
Proceeds from sale of assets 13,045 8,745
Capital expenditures (3,425) (10,114)
Cash paid in connection with acquisitions, net of cash acquired (1,800)  
Net cash provided by (used in) investing activities 7,843 (1,335)
Cash flows from financing activities:    
Borrowings under the Credit Facility 24,705 29,000
Repayments on the Credit Facility (35,000) (18,500)
Payments of finance lease obligations (1,123) (791)
Distributions paid on distribution equivalent rights (69) (73)
Distributions paid on common units (20,021) (19,981)
Net cash used in financing activities (31,508) (10,345)
Net increase in cash and cash equivalents 4,212 3,367
Cash and cash equivalents at beginning of period 3,137 3,381
Cash and cash equivalents at end of period $ 7,349 $ 6,748